Metis Global Partners, LLC Amgen Inc Transaction History

Metis Global Partners, LLC

$3.16 Billion
Q3 2024

A detailed history of Metis Global Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Metis Global Partners, LLC holds 25,755 shares of AMGN stock, worth $6.78 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

25,755

Previous 25,098 2.62%

Holding current value

$6.78 Million

Previous $7.84 Million 5.83%

% of portfolio

0.26%

Previous 0.27%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$309.38 - $337.38 $203,262 - $221,658	657 Added 2.62%	25,755 $8.3 Million
Q2 2024 Aug 06, 2024	BUY	$262.75 - $319.31 $156,073 - $189,670	594 Added 2.42%	25,098 $7.84 Million
Q1 2024 May 06, 2024	BUY	$268.87 - $324.56 $70,981 - $85,683	264 Added 1.09%	24,504 $6.97 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $295,333 - $333,171	-1,155 Reduced 4.55%	24,240 $6.98 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $790,638 - $981,599	3,616 Added 16.6%	25,395 $6.83 Million
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $64,281 - $76,011	-300 Reduced 1.36%	21,779 $4.84 Million
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $1.45 Million - $1.76 Million	6,401 Added 40.83%	22,079 $5.34 Million
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $1.55 Million - $1.97 Million	6,753 Added 75.66%	15,678 $4.12 Million
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $43,769 - $49,364	195 Added 2.23%	8,925 $2.01 Million
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $37,605 - $41,848	-163 Reduced 1.83%	8,730 $2.12 Million
Q1 2022 May 03, 2022	BUY	$219.27 - $242.57 $865,020 - $956,938	3,945 Added 79.73%	8,893 $2.15 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $984,058 - $1.13 Million	4,948 New	4,948 $1.11 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Metis Global Partners, LLC with notifications on news.

Account

Metis Global Partners, LLC Amgen Inc Transaction History